The MLSC has received eighty-eight applications for the Center’s Accelerator loan program for early-stage companies. The first round of applications began on January 1, 2009 and closed on March 6, 2009.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.